Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133)-Reference-Cited by-同舟云学术

Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133)

Published:2019-11 Issue:6 Volume:20 Page:469-476.e1
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Nishio Makoto,Sugawara Shunichi,Atagi Shinji,Akamatsu Hiroaki,Sakai Hiroshi,Okamoto Isamu,Takayama Koichi,Hayashi Hidetoshi,Nakagawa Yuki,Kawakami Tomohisa

Funder

F. Hoffmann-La Roche Ltd

Ono Pharmaceutical

Bristol-Myers Squibb

Pfizer

Chugai Pharmaceutical

Eli Lilly

Taiho Pharmaceutical

AstraZeneca

MSD

Novartis

Astellas

Boehringer Ingelheim

MSD K.K.

F. Hoffman-La Roche Ltd

MSD Oncology

Astellas Pharma

AbbVie

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Small cell lung cancer: where do we go from here?;Byers;Cancer,2015

2. NCCN Clinical Practice Guidelines in Oncology: Small Cell Lung Cancer (Version 1.2019). 2019;;National Comprehensive Cancer Network,2019

3. Comparison and discussion of the treatment guidelines for small cell lung cancer;Zhao;Thorac Cancer,2018

4. Current standards for clinical management of small cell lung cancer;Farago;Transl Lung Cancer Res,2018

5. Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer;Socinski;J Clin Oncol,2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer;International Journal of Clinical Oncology;2024-07-15

2. Relationship between expression of CD155 and TIGIT and clinicopathological features in gastrointestinal neuroendocrine tumors;World Chinese Journal of Digestology;2024-02-28

3. Promises of Protein Kinase Inhibitors in Recalcitrant Small-Cell Lung Cancer: Recent Scenario and Future Possibilities;Cancers;2024-02-27

4. Neurotoxicity Associated with Immunotherapy for Lung Cancer in Clinical Trials: A Systematic Review and Meta-Analysis;2024

5. Relationship between immune‐related adverse events and treatment effectiveness in extensive disease small cell lung cancer;Thoracic Cancer;2023-06-26